PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
17.91
+0.40 (2.28%)
At close: Oct 7, 2026, 4:00 PM EDT
17.74
-0.17 (-0.95%)
Pre-market: Oct 8, 2026, 4:16 AM EDT
PROCEPT BioRobotics Market Cap
PROCEPT BioRobotics has a market cap or net worth of $1.03 billion as of October 7, 2026. That makes PROCEPT BioRobotics the 10,168th most valuable company in the world and 2,229th in the United States. Its market cap has decreased by 47.68% in one year.
Market Cap
1.03B
Enterprise Value
875.36M
1-Year Change
-47.68%
Global Rank
Country Rank
#2,229 United States
Category
ChartMarket Cap Chart
Since the IPO on September 15, 2021, PROCEPT BioRobotics's market cap has decreased from $1.06B to $1.03B, a decrease of -2.93%. That is a compound annual growth rate of -0.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 1.03B | -41.65% |
| Dec 31, 2025 | 1.76B | -59.65% |
| Dec 31, 2024 | 4.36B | 105.85% |
| Dec 29, 2023 | 2.12B | 13.93% |
| Dec 30, 2022 | 1.86B | 70.76% |
| Dec 31, 2021 | 1.09B | 2.94% |
| Sep 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tandem Diabetes Care | 1.15B |
| Bioventus | 1.14B |
| IRADIMED CORPORATION | 1.10B |
| Artivion | 1.10B |
| Enovis | 1.08B |
| Lumexa Imaging Holdings | 1.03B |
| Integra LifeSciences Holdings | 1.03B |
| Beta Bionics | 994.93M |